August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
New Delhi, India (July 28, 2022) Problem: A gap in the ability of clients to make informed decisions on family planning choices Public health facilities in India are often overloaded with emergency and high priority cases, making family planning and reproductive health—for youth, women and couples—a secondary concern for health care providers. And while ASHAs,
Dr. Christopher Morgan, Jhpiego’s Senior Technical Advisor on immunizations, responds to the WHO-UNICEF report on the alarming rise in unvaccinated children: “The rise in unimmunized children in 2021 is extremely alarming. There is now an historically large pool who are vulnerable to future outbreaks. Our work on COVID-19 vaccination must go hand in hand with
